Abstract
Introduction and hypothesis
Bulking agents are a minimally invasive treatment option for women with stress urinary incontinence (SUI) or stress-predominant mixed urinary incontinence (MUI). Recurrent SUI is a major challenge for most clinicians because there is little evidence in the literature on the best option after midurethral sling (MUS) failure.
Methods
Bulkamid® (Contura International A/S), a urethral bulking agent, is a homogenous gel without particles, consisting of a polyacrylamide hydrogel that is nonbiodegradable.
Results
In this video case report, we demonstrate the Bulkamid® injection procedure. This procedure can be carried out as an office-based procedure under local anesthesia, with no down time and only minor possible complications.
Conclusions
We consider it a valid option for patients with recurrent or persistent SUI after failed MUS surgery.
References
Brosche T, Kuhn A, Lobodasch K, Sokol ER. Seven-year efficacy and safety outcomes of Bulkamid for the treatment of stress urinary incontinence. Neurourol Urodyn. 2021;40:502–8. https://doi.org/10.1002/nau.24589.
Zheng Y, Rovner E. Update on urethral bulking for stress urinary incontinence in women. Curr Urol Rep. 2022;23(10):203–9. https://doi.org/10.1007/s11934-022-01099-5.
Hoe V, Haller B, Yao HH, O’Connell HE. Urethral bulking agents for the treatment of stress urinary incontinence in women: a systematic review. Neurourol Urodyn. 2021;40:1349–88. https://doi.org/10.1002/nau.24696.
Braga A, Caccia G, Papadia A, et al. Urethral bulking agents for the treatment of recurrent stress urinary incontinence: a systematic review and meta-analysis. Maturitas. 2022;163:28–37. https://doi.org/10.1016/j.maturitas.2022.05.007.
Kobashi K, Albo M, Dmochowski R, et al. American Urological Association stress-urinary-incontinence guideline. 2017. https://www.auanet.org/guidelines-and-quality/guidelines/stress-urinary-incontinence-(sui)-guideline. Accessed 30 Mar 2023.
Nambiar AK, Arlandis S, Bø K, et al. European Association of Urology guidelines on the diagnosis and management of female non-neurogenic lower urinary tract symptoms. I. Diagnostics, overactive bladder, stress urinary incontinence, and mixed urinary incontinence. Eur Urol. 2022;82(1):49–59. https://doi.org/10.1016/j.eururo.2022.01.045.
Itkonen Freitas AM, Mentula M, Rahkola-Soisalo P, Tulokas S, Mikkola TS. Tension-free vaginal tape surgery versus polyacrylamide hydrogel injection for primary stress urinary incontinence: a randomized clinical trial. J Urol. 2020;203(2):372–8. https://doi.org/10.1097/JU.0000000000000517.
Itkonen Freitas AM, Isaksson C, Rahkola-Soisalo P, Tulokas S, Mentula M, Mikkola TS. Tension-free vaginal tape and polyacrylamide hydrogel injection for primary stress urinary incontinence: 3-year followup from a randomized clinical trial. J Urol. 2022;208(3):658–67. https://doi.org/10.1097/JU.0000000000002720.
Castro-Diaz D. When do I go for AUS or bulking agents? In management of female stress urinary incontinence after a failed midurethral sling. ICS 2018. Available online: https://www.ics.org/2018/session/3865. Accessed 28 February 2023.
Acknowledgements
Thanks to Thibaud Vernet, MD, for ultrasound images, Miha Brvar for help with the graphic design, and Donald Reindl for assistance with copyediting this manuscript.
Funding
This research received no external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Consent
Written informed consent was obtained from the patient for publication of this video article.
Financial disclaimer
All the authors completed the International Committee of Medical Journal Editors uniform disclosure form.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
(MP4 94539 kb)
Rights and permissions
About this article
Cite this article
Lukanović, D., Blaganje, M., Rhazi, I. et al. Urethral Bulkamid® injection after failed midurethral sling: a step-by-step video. Int Urogynecol J 34, 2843–2845 (2023). https://doi.org/10.1007/s00192-023-05608-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-023-05608-z